Digital therapeutics Market by Region – Global Opportunities & Forecast, 2020-2027
Global Digital Therapeutics Market
The Digital
Therapeutics Market is likely to perceive a spectacular growth rate of
23.1% over the forecast period. The growing occurrence of chronic diseases,
which include diabetes and cardiovascular diseases, has stimulated the growth
of the market.
Request
a FREE Sample Report of Digital Therapeutics Market
Digital
Therapeutics Market Dynamics
The rising incidence of incurable diseases is the standalone
factor responsible for the growth of the global digital therapeutics market.
Individuals suffering from chronic disorders, such as high blood pressure and
acute obstructive diseases, have raised the annual cost of the US healthcare
system. In accordance with the Centres for Disease Control and Prevention, 6
out of 10 individuals in the United States got infected from at least one acute
disease, with nearly 4 out of 10 having two or more. The Digital
therapeutics Market global forecast states that the increasing
incidences of chronic diseases are gauged for USD 3.8 trillion yearly health
care costs. The acquisition of evidence-based digital therapies has encouraged
healthcare organizations to reduce the surging cost of nursing the accelerating
number of patients with incurable health diseases. For example, verily
introduced a study watch with inconstant pulse administer in partnership with rhythm
for data analytics and cloud-based machine learning and constant supervision to
produce solutions for examination of atrial fibrillation. However, as per the Digital therapeutics Market report
the inconstancy associated with the legal ground for data processing in digital
health matters has restrained the market growth. Modification in the system by
the integration of digital health is a complicated, expensive, and discursive
task and requires conciliation of all parties. The prerequisites of digital
therapeutics are data rights and cybersecurity. With the exchange of
information over the internet, the incidences of unsanctioned access and
intrigue of these items compromise trust in the patient care and product.
Application
Segment Drivers
Based on the application, the Diabetes segment is
anticipated to lead the digital therapies market over the coming years majorly
because of the accelerating cases of diabetes globally. Moreover, the
introduction of strategic diabetes and lifestyle administration programs such
as "LIFEMAP," has supplemented the Digital therapeutics Market
size.
About GMI
Research
GMI Research is a market research and consulting firm which
provides market insights and intelligence across 12 major sectors helping our clients
in making effective investment and business decisions.
Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: enquiry@gmiresearch.com
Phone: Europe – +353 1 442 8820; US – +1 860 881 2270
Address: Dublin, Ireland
Website:
www.gmiresearch.com
For More info:
Comments
Post a Comment